Interestingly, loss of WFS1 activity is also associated with increased risk of psychiatric disorders [529,530,531], as well as juvenile-onset diabetes, progressive neurologic degeneration, and endocrine dysfunction [532,533]. Here, WFS1 is linked to psychiatric disorder.